A 60-year-old female had a right colectomy for adenocarcinoma of the colon. At the time of surgery, she had 7 liver metastases that were treated with radiowave ablation. Thirteen lymph nodes were ...

Patients with colorectal cancer (CRC) liver metastases had reduced risk of intrahepatic recurrence when using intraoperative contrast-enhanced ultrasounds. A new study published in Digestive and Liver ...

Combining surgery with chemotherapy significantly improves survival in GIST patients with liver metastases compared to chemotherapy alone. Median CSS and OS for combined treatment exceed 120 months, ...

With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...

What is the best upfront chemotherapy option for patients with colorectal cancer (CRC) and unresectable liver metastases? A new report demonstrated why patients benefit most from starting on a ...

90Y-SIRT offers significant hepatic progression-free survival for GIST patients with liver metastases resistant to TKI therapy, with a median of 16 months. Patients with quadruple wildtype mutation ...

When physicians prescribe systemic chemotherapy, they need to strike a careful balance: the dose needs be strong enough to kill cancer cells throughout the body but not so strong that it harms healthy ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...